Thomas W. Jobling

Abstract PR002: Breaking Barriers in Rare Cancer Research: Patient-Partnered Research via Social Media as a Model for Generating Evidence in Granulosa Cell Tumor of the Ovary

Simon Chu, Victoria White, Linda M Langdale, Kim D Eroh et autres

au, il (code pays fourni par la source)

Perioperative ctDNA as a prognostic biomarker in endometrial cancer - the CODEC study

Rachel Delahunty, Madawa Jayawardana, Rainier Arnolda, Thuan Tzen Koh et autres

au (code pays fourni par la source)

Experiences of radiotherapy for treatment of Granulosa Cell Tumor of the ovary: insights from the GCT-survivor sisters

Victoria White, Linda M Langdale, Kim D Eroh, M. Kaye Ackermann et autres

au, il (code pays fourni par la source)

Erratum to ‘Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma’ [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101644]

Andreas Obermair, Val Gebski, Jeffrey C. Goh, Anna Kuchel et autres

au, us (code pays fourni par la source)

Physical Activity, Quality of Life, and Pelvic Floor Disorders Before and After Hysterectomy for Gynecological Cancer: A Prospective Cohort Study

Robyn Brennen, Kuan‐Yin Lin, Linda Denehy, Sze‐Ee Soh et autres

au, fr, tw (code pays fourni par la source)

A Novel 3D High‐Throughput Phenotypic Drug Screening Pipeline to Identify Drugs with Repurposing Potential for the Treatment of Ovarian Cancer

Nazanin Karimnia, Amy Wilson, Brittany R. Doran, Judy Do et autres

au (code pays fourni par la source)

Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma

Andreas Obermair, Val Gebski, Jeffrey C. Goh, Anna Kuchel et autres

au, us (code pays fourni par la source)

Leader cells promote immunosuppression to drive ovarian cancer progression in vivo

Amy L Wilson, Laura R. Moffitt, Brittany R. Doran, Bashira Basri et autres

au (code pays fourni par la source)

EV306/#612 Patterns of ovarian cancer care and overall survival in Australia: a prospective study from the National Gynae-Oncology Registry (NGOR)

Mahendra Naidoo, Orla Mcnally, Clare L. Scott, Michael Friedländer et autres

Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer

Nikki Burdett, Madelynne O. Willis, Ahwan Pandey, Laura Twomey et autres

au (code pays fourni par la source)

Natural history of pelvic floor disorders before and after hysterectomy for gynaecological cancer

Robyn Brennen, Kuan‐Yin Lin, Linda Denehy, Sze‐Ee Soh et autres

au, tw (code pays fourni par la source)

Abstract B019: Assessing Circulating TumOur DNA as a prognostic biomarker in endometrial cancer (The CODEC Study)

Rachel Delahunty, Rainier Arnolda, Thuan Tzen Koh, Michael S. Hofman et autres

au (code pays fourni par la source)